Koko Mahmoud, Yahia Ashraf, Elsayed Liena E, Hamed Ahlam A, Mohammed Inaam N, Elseed Maha A, Hamad Muddathir H A, Babai Arwa M, Siddig Rayan A, Abd Allah Amal S I, Mohamed Mayada, El-Amin Melka, Esteves Typhaine, Altmüller Janine, Toliat Mohammad Reza, Thiele Holger, Nürnberg Peter, Salih Mustafa A, Ahmed Ammar E, Lerche Holger, Stevanin Giovanni
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen, Tubingen, Germany.
Department of Biochemistry, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Ann Hum Genet. 2021 Sep;85(5):186-195. doi: 10.1111/ahg.12437. Epub 2021 Jun 10.
PRUNE1 is linked to a wide range of neurodevelopmental and neurodegenerative phenotypes. Multiple pathogenic missense and stop-gain PRUNE1 variants were identified in its DHH and DHHA2 phosphodiesterase domains. Conversely, a single splice alteration was previously reported. We investigated five patients from two unrelated consanguineous Sudanese families with an inherited severe neurodevelopmental disorder using whole-exome sequencing coupled with homozygosity mapping, segregation, and haplotype analysis. We identified a founder haplotype transmitting a homozygous canonical splice-donor variant (NM_021222.3:c.132+2T > C) in intron 2 of PRUNE1 segregated with the phenotype in all the patients. This splice variant possibly results in an in-frame deletion in the DHH domain or premature truncation of the protein. The phenotypes of the affected individuals showed phenotypic similarities characterized by remarkable pyramidal dysfunction and prominent extrapyramidal features (severe dystonia and bradykinesia). In conclusion, we identified a novel founder variant in PRUNE1 and corroborated abnormal splicing events as a disease mechanism in PRUNE1-related disorders. Given the phenotypes' consistency coupled with the founder effect, canonical and cryptic PRUNE1 splice-site variants should be carefully evaluated in patients presenting with prominent dystonia and pyramidal dysfunction.
PRUNE1与多种神经发育和神经退行性表型相关。在其DHH和DHHA2磷酸二酯酶结构域中鉴定出多个致病性错义突变和获得性终止PRUNE1变体。相反,先前报道过一个单一的剪接改变。我们使用全外显子组测序结合纯合性定位、分离分析和单倍型分析,对来自两个不相关的苏丹近亲家庭的五名患有遗传性严重神经发育障碍的患者进行了研究。我们鉴定出一个奠基者单倍型,其传递了PRUNE1第2内含子中的一个纯合典型剪接供体变体(NM_021222.3:c.132+2T>C),该变体在所有患者中均与表型分离。这种剪接变体可能导致DHH结构域中的框内缺失或蛋白质的过早截断。受影响个体的表型表现出以明显的锥体功能障碍和突出的锥体外系特征(严重肌张力障碍和运动迟缓)为特征的表型相似性。总之,我们在PRUNE1中鉴定出一个新的奠基者变体,并证实异常剪接事件是PRUNE1相关疾病的一种发病机制。鉴于表型的一致性以及奠基者效应,对于表现出明显肌张力障碍和锥体功能障碍的患者,应仔细评估典型和隐匿性PRUNE1剪接位点变体。